Glucagon-Like Peptide-1 Receptor Agonists for Chronic Weight Management

Rates of obesity have risen over the past few decades. Subsequently, popularity pharmaceutical weight-loss drug market has grown years to meet growing demand. Among most commonly prescribed drugs for weight management, many are glucagon-like peptide-1 receptor agonists (GLP-1 agonists) which also utilized management type 2 diabetes. There is a substantial and body research comparing efficacy different clinical trials examining long-term safety. This literature review examines rise off-label prescribing practices in weight, with focus on GLP-1 agonists. Physicians patients should be aware unique aspects existing treatment options, impacts prescribing, effects these medications. emphasizes importance informed decision-making, as well need further guide future practice.